Maitreya Medicare Ltd

Maitreya Medica. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Maitreya Medicare Ltd

₹ 186 5.14%
29 Apr 11:06 a.m.
maitreyahospitals.com NSE - SME: MAITREYA
About

Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]

Key Points

Integrated Healthcare Provider[1] Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.

Website NSE - SM
  • Market Cap ₹ 126 Cr.
  • Current Price ₹ 186
  • High / Low ₹ 308 / 153
  • Stock P/E 180
  • Book Value ₹ 46.8
  • Dividend Yield 0.00 %
  • ROCE 11.3 %
  • ROE 7.28 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 18.6%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 108 to 130 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
24.28 22.25 22.18 22.23 23.28
19.86 20.51 19.45 20.08 22.11
Operating Profit 4.42 1.74 2.73 2.15 1.17
OPM % 18.20% 7.82% 12.31% 9.67% 5.03%
0.05 0.17 0.14 0.30 0.14
Interest 0.39 0.35 0.38 0.37 0.37
Depreciation 0.63 0.63 0.63 0.71 0.71
Profit before tax 3.45 0.93 1.86 1.37 0.23
Tax % 28.99% 22.58% 27.42% 59.12% 34.78%
2.45 0.72 1.35 0.55 0.15
EPS in Rs 4.94 1.06 1.99 0.81 0.22
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
8.40 55.73 48.14 38.38 44.85 42.74 45.51
7.74 48.42 45.21 31.22 38.69 37.86 42.19
Operating Profit 0.66 7.31 2.93 7.16 6.16 4.88 3.32
OPM % 7.86% 13.12% 6.09% 18.66% 13.73% 11.42% 7.30%
0.04 0.46 0.44 0.52 0.22 0.44 0.44
Interest 0.31 0.79 0.76 0.57 0.74 0.75 0.74
Depreciation 0.34 1.00 1.20 1.27 1.26 1.35 1.42
Profit before tax 0.05 5.98 1.41 5.84 4.38 3.22 1.60
Tax % 220.00% 26.09% 24.11% 28.25% 27.85% 40.99%
-0.06 4.41 1.07 4.19 3.17 1.90 0.70
EPS in Rs -60.00 4,410.00 1,070.00 8.45 4.68 2.80 1.03
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 38%
3 Years: -4%
TTM: 2%
Compounded Profit Growth
10 Years: %
5 Years: 102%
3 Years: 23%
TTM: -66%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -41%
Return on Equity
10 Years: %
5 Years: 26%
3 Years: 19%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.01 0.01 0.01 4.96 6.78 6.78 11.55
Reserves -0.05 4.36 5.48 3.82 18.08 19.98 20.13
12.13 14.24 12.38 11.59 9.46 8.85 2.70
2.30 7.28 4.96 7.38 6.20 8.80 11.27
Total Liabilities 14.39 25.89 22.83 27.75 40.52 44.41 45.65
9.33 13.81 13.50 11.51 10.94 11.97 11.58
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.41 1.54 0.36 0.70 3.61 7.63 7.61
4.65 10.54 8.97 15.54 25.97 24.81 26.46
Total Assets 14.39 25.89 22.83 27.75 40.52 44.41 45.65

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1.23 4.91 0.77 2.42 -0.26 5.03
-12.17 -5.63 0.16 0.36 -5.57 -7.20
11.88 1.51 -2.61 -1.34 10.00 -1.58
Net Cash Flow 0.94 0.79 -1.68 1.43 4.18 -3.75
Free Cash Flow -8.44 -0.57 -0.12 2.99 -0.94 2.66
CFO/OP 152% 78% 26% 38% 25% 133%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31.72 30.78 40.94 88.06 106.37 129.64
Inventory Days 171.39 62.04 40.82 69.86 29.89 29.95
Days Payable 558.61 230.96 221.25 317.85 149.43 173.45
Cash Conversion Cycle -355.50 -138.13 -139.49 -159.93 -13.18 -13.87
Working Capital Days 0.87 4.13 16.83 26.63 60.30 57.56
ROCE % 43.19% 11.40% 33.68% 18.61% 11.30%

Insights

In beta
Mar 2019 Mar 2021 Mar 2022 Mar 2023 Nov 2024 Nov 2025
Number of Hospitals
Number

Log in to view insights

Please log in to see hidden values.

Login
Total Bed Capacity
Number of Beds
Bed Capacity Utilization
Percentage
OPD Capacity (Prannath Hospital)
Visits per day
OPD Capacity (Surat)
Visits per day
Operational Bed Capacity (Used)
Number of Beds

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
73.11% 73.11% 73.11% 73.00% 73.11%
2.53% 0.41% 0.01% 0.00% 0.00%
1.35% 0.00% 0.00% 0.00% 0.00%
23.02% 26.48% 26.88% 27.00% 26.89%
No. of Shareholders 474907986978976

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Nov 2025
    Transcript
    AI Summary
    PPT
  • Sep 2025
    Transcript
    AI Summary
    PPT
  • Nov 2024
    Transcript PPT
  • May 2024
    Transcript
    AI Summary
    PPT
  • Feb 2024
    Transcript PPT